A Human-Immune-System mouse model for COVID-19 research(DRAGA mouse: HLA-A2.HLA-DR4.Rag1KO.IL-2Rγc KO.NOD)
Brumeanu, T.-D.; Vir, P.; Shashikumar, S.; Karim, A. F.; Kar, S.; Chung, K. K.; Pratt, K. P.; Casares, S. A.
Show abstract
We report the first Human Immune System (HIS)-humanized mouse model ("DRAGA": HLA-A2.HLA-DR4.Rag1KO.IL-2R{gamma}cKO.NOD) for COVID-19 research. This mouse is reconstituted with human cord blood-derived, HLA-matched hematopoietic stem cells. It engrafts human epi/endothelial cells expressing the human ACE2 receptor for SARS-CoV-2 and TMPRSS2 serine protease co-localized on lung epithelia. HIS-DRAGA mice sustained SARS-CoV-2 infection, showing deteriorated clinical condition, replicating virus in the lungs, and human-like lung immunopathology including T-cell infiltrates, microthrombi and pulmonary sequelae. Among T-cell infiltrates, lung-resident (CD103+) CD8+ T cells were sequestered in epithelial (CD326+) lung niches and secreted granzyme B and perforin, indicating cytotoxic potential. Infected mice also developed antibodies against the SARS-CoV-2 viral proteins. Hence, HIS-DRAGA mice showed unique advantages as a surrogate in vivo human model for studying SARS-CoV-2 immunopathology and for testing the safety and efficacy of candidate vaccines and therapeutics.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19 97%
- Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates 96%
- Gasdermin D promotes influenza virus-induced mortality through neutrophil amplification of inflammation 96%
Similar papers in this journal
- Fibroblast growth factor-9 expression in airway epithelial cells amplifies the type I interferon response and alters influenza A virus pathogenesis 97%
- Immune Signatures of SARS-CoV-2 Infection Resolution in Human Lung Tissues 96%
- Inflammasome activation and pulmonary viral loads define two distinct clinical outcomes in COVID-19 96%
Similar papers in this journal
- Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epithelia 96%
- Immunogenicity and Protective Efficacy of an Intranasal Live-attenuated Vaccine Against SARS-CoV-2 in Preclinical Animal Models 94%
- Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expression 94%
Similar papers in this journal
- Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease 95%
- Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injury 95%
- Loss of Fas-signaling in pro-fibrotic fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.